FULC Earnings

FULC reported its earnings on 2026-04-27, showcasing a revenue of 0.00 against an estimate of , resulting in a 0% surprise. The EPS was -0.25, surpassing the expected -0.31 by 19.35%. The stock experienced a -1.53% price change on the earnings day and a -9.06% change over the next five days, reflecting market reactions to the results.

Following FULC's earnings announcement on 2026-04-27, the stock price moved by -1.53% on the day of the release. Over the subsequent five days, it saw a -9.06% change. Historically, FULC's stock price tends to shift by an average of -6.34% in the 10 days leading up to earnings and 1.17% in the 10 days following, providing insight into potential market.

For , analysts estimate FULC's annual revenue to reach , while the EPS is projected at -0.29. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised downward by -35.54% over the past three months, indicating analyst expectation in the company's performance.

The correlation between FULC's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised downward by -35.54%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, FULC's stock price typically moves by -6.34% in the 10 days before its earnings and 1.17% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -0.29 and revenue of .

The earnings call presents a mixed picture. Basic financial performance shows increased revenue but also higher expenses and net losses, which is neutral. Product development updates are positive with plans for trials and EMA engagement, but lack of new data disclosures tempers this. Market strategy is cautiously optimistic with a head start in treatment landscape. Financial health is stable but declining cash reserves are concerning. Shareholder return plans are not mentioned, leaving an incomplete picture. Overall, the sentiment is balanced, leading to a neutral prediction.